S&P 500   5,068.14 (+1.73%)
DOW   38,894.28 (+0.73%)
QQQ   436.08 (+2.46%)
AAPL   182.88 (+0.31%)
MSFT   410.05 (+1.96%)
META   486.48 (+3.94%)
GOOGL   143.43 (+0.62%)
AMZN   172.24 (+2.17%)
TSLA   193.67 (-0.56%)
NVDA   778.17 (+15.33%)
NIO   5.73 (-4.02%)
AMD   183.19 (+11.50%)
BABA   75.56 (-0.03%)
T   16.66 (-2.00%)
F   12.16 (+0.16%)
MU   85.79 (+5.28%)
CGC   3.39 (-1.45%)
GE   151.56 (+1.67%)
DIS   108.26 (+0.55%)
AMC   4.40 (-3.72%)
PFE   27.26 (-1.48%)
PYPL   58.39 (+1.58%)
XOM   105.18 (+0.31%)
S&P 500   5,068.14 (+1.73%)
DOW   38,894.28 (+0.73%)
QQQ   436.08 (+2.46%)
AAPL   182.88 (+0.31%)
MSFT   410.05 (+1.96%)
META   486.48 (+3.94%)
GOOGL   143.43 (+0.62%)
AMZN   172.24 (+2.17%)
TSLA   193.67 (-0.56%)
NVDA   778.17 (+15.33%)
NIO   5.73 (-4.02%)
AMD   183.19 (+11.50%)
BABA   75.56 (-0.03%)
T   16.66 (-2.00%)
F   12.16 (+0.16%)
MU   85.79 (+5.28%)
CGC   3.39 (-1.45%)
GE   151.56 (+1.67%)
DIS   108.26 (+0.55%)
AMC   4.40 (-3.72%)
PFE   27.26 (-1.48%)
PYPL   58.39 (+1.58%)
XOM   105.18 (+0.31%)
S&P 500   5,068.14 (+1.73%)
DOW   38,894.28 (+0.73%)
QQQ   436.08 (+2.46%)
AAPL   182.88 (+0.31%)
MSFT   410.05 (+1.96%)
META   486.48 (+3.94%)
GOOGL   143.43 (+0.62%)
AMZN   172.24 (+2.17%)
TSLA   193.67 (-0.56%)
NVDA   778.17 (+15.33%)
NIO   5.73 (-4.02%)
AMD   183.19 (+11.50%)
BABA   75.56 (-0.03%)
T   16.66 (-2.00%)
F   12.16 (+0.16%)
MU   85.79 (+5.28%)
CGC   3.39 (-1.45%)
GE   151.56 (+1.67%)
DIS   108.26 (+0.55%)
AMC   4.40 (-3.72%)
PFE   27.26 (-1.48%)
PYPL   58.39 (+1.58%)
XOM   105.18 (+0.31%)
S&P 500   5,068.14 (+1.73%)
DOW   38,894.28 (+0.73%)
QQQ   436.08 (+2.46%)
AAPL   182.88 (+0.31%)
MSFT   410.05 (+1.96%)
META   486.48 (+3.94%)
GOOGL   143.43 (+0.62%)
AMZN   172.24 (+2.17%)
TSLA   193.67 (-0.56%)
NVDA   778.17 (+15.33%)
NIO   5.73 (-4.02%)
AMD   183.19 (+11.50%)
BABA   75.56 (-0.03%)
T   16.66 (-2.00%)
F   12.16 (+0.16%)
MU   85.79 (+5.28%)
CGC   3.39 (-1.45%)
GE   151.56 (+1.67%)
DIS   108.26 (+0.55%)
AMC   4.40 (-3.72%)
PFE   27.26 (-1.48%)
PYPL   58.39 (+1.58%)
XOM   105.18 (+0.31%)

eFFECTOR Therapeutics (EFTR) Short Interest Ratio & Short Volume

$10.74
-0.10 (-0.92%)
(As of 11:19 AM ET)

eFFECTOR Therapeutics Short Interest Data

Current Short Volume
108,800 shares
Previous Short Volume
124,500 shares
Change Vs. Previous Month
-12.61%
Dollar Volume Sold Short
$1.25 million
Short Interest Ratio / Days to Cover
1.0
Last Record Date
January 31, 2024
Outstanding Shares
2,580,000 shares
Float Size
1,850,000 shares
Short Percent of Float
5.88%
Today's Trading Volume
22,206 shares
Average Trading Volume
109,788 shares
Today's Volume Vs. Average
20%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling eFFECTOR Therapeutics ?

Sign up to receive the latest short interest report for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EFTR Short Interest Over Time

EFTR Days to Cover Over Time

EFTR Percentage of Float Shorted Over Time


eFFECTOR Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024108,800 shares $1.25 million -12.6%5.9%1 $11.47
1/15/2024124,500 shares $1.33 million -85.0%6.7%1.3 $10.69
12/31/2023827,900 shares $386,960.46 -21.9%1.8%0.4 $0.47
12/15/20231,060,000 shares $398,348.00 +1.0%2.3%0.6 $0.38
11/30/20231,050,000 shares $556,920.00 +141.9%2.3%0.8 $0.53
11/15/2023434,000 shares $253,890.00 +72.8%1.0%0.6 $0.59
10/31/2023251,100 shares $135,594.00 -50.5%0.7%0.6 $0.54
10/15/2023507,600 shares $291,057.84 +133.9%1.3%1.1 $0.57
9/30/2023217,000 shares $130,178.30 -74.0%0.6%0.5 $0.60
9/15/2023834,100 shares $508,801.00 -8.5%2.2%1.4 $0.61
8/31/2023912,000 shares $663,936.00 +36.7%2.4%1 $0.73
8/15/2023667,400 shares $453,231.34 -38.8%1.7%0.3 $0.68
7/31/20231,090,000 shares $881,156.00 -15.5%3.6%0.5 $0.81
7/15/20231,290,000 shares $990,720.00 +219.3%4.2%0.6 $0.77
6/30/2023404,000 shares $335,400.80 +91.4%1.4%0.2 $0.83
6/15/2023211,100 shares $197,378.50 -83.0%0.8%0.1 $0.94
5/31/20231,240,000 shares $1.15 million +1,506.2%4.6%0.8 $0.93
5/15/202377,200 shares $52,874.28 -12.6%0.4%0.4 $0.68
4/30/202388,300 shares $41,501.00 -32.5%0.6%0.5 $0.47
4/15/2023130,800 shares $50,358.00 +236.3%0.7%0.7 $0.39
3/31/202338,900 shares $13,720.03 -45.2%0.1%0.2 $0.35
3/15/202371,000 shares $28,400.00 +110.7%0.2%0.2 $0.40
2/28/202333,700 shares $16,789.34 -72.2%0.3%0.1 $0.50
2/15/2023121,300 shares $72,780.00 -9.1%0.9%0.4 $0.60
1/31/2023133,400 shares $68,447.54 -29.3%1.0%0.4 $0.51
1/15/2023188,800 shares $84,960.00 +56.4%1.4%0.7 $0.45
12/30/2022120,700 shares $51,611.32 +148.9%0.9%0.5 $0.43
12/15/202248,500 shares $19,400.00 +41.4%0.4%0.5 $0.40
11/30/202234,300 shares $14,399.14 -49.9%0.3%0.3 $0.42
11/15/202268,400 shares $37,695.24 -51.7%0.5%0.5 $0.55
10/31/2022141,600 shares $86,758.32 +13.2%1.1%0.1 $0.61
10/15/2022125,100 shares $73,296.09 -42.5%1.0%0.1 $0.59
9/30/2022217,500 shares $124,431.75 +55.0%1.7%0.2 $0.57
9/15/2022140,300 shares $83,071.63 -25.5%1.1%0.1 $0.59
8/31/2022188,300 shares $114,768.85 +21.5%1.4%0.2 $0.61
8/15/2022155,000 shares $111,026.50 +104.8%1.3%0.1 $0.72
7/31/202275,700 shares $61,301.86 -19.5%1.0%0.1 $0.81
7/15/202294,000 shares $105,280.00 -30.4%1.2%1.5 $1.12
6/30/2022135,000 shares $191,700.00 -12.0%1.8%3.1 $1.42
6/15/2022153,400 shares $225,498.00 -13.2%2.0%4 $1.47













EFTR Short Interest - Frequently Asked Questions

What is eFFECTOR Therapeutics' current short interest?

Short interest is the volume of eFFECTOR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 108,800 shares of EFTR short. 5.88% of eFFECTOR Therapeutics' shares are currently sold short. Learn More on eFFECTOR Therapeutics' current short interest.

What is a good short interest ratio for eFFECTOR Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EFTR shares currently have a short interest ratio of 1.0. Learn More on eFFECTOR Therapeutics's short interest ratio.

What is a good short interest percentage for eFFECTOR Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.88% of eFFECTOR Therapeutics' floating shares are currently sold short.

Is eFFECTOR Therapeutics' short interest increasing or decreasing?

eFFECTOR Therapeutics saw a decline in short interest in January. As of January 31st, there was short interest totaling 108,800 shares, a decline of 12.6% from the previous total of 124,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is eFFECTOR Therapeutics' float size?

eFFECTOR Therapeutics currently has issued a total of 2,580,000 shares. Some of eFFECTOR Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. eFFECTOR Therapeutics currently has a public float of 1,850,000 shares.

How does eFFECTOR Therapeutics' short interest compare to its competitors?

5.88% of eFFECTOR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to eFFECTOR Therapeutics: Owlet, Inc. (4.93%), ImmuCell Co. (0.14%), Rain Oncology Inc. (2.42%), Unicycive Therapeutics, Inc. (0.27%), Immix Biopharma, Inc. (6.42%), NeuroOne Medical Technologies Co. (0.35%), Surrozen, Inc. (0.27%), Ekso Bionics Holdings, Inc. (1.70%), Freeline Therapeutics Holdings plc (0.58%), DURECT Co. (3.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short eFFECTOR Therapeutics stock?

Short selling EFTR is an investing strategy that aims to generate trading profit from eFFECTOR Therapeutics as its price is falling. EFTR shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against eFFECTOR Therapeutics?

A short squeeze for eFFECTOR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EFTR, which in turn drives the price of the stock up even further.

How often is eFFECTOR Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFTR, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:EFTR) was last updated on 2/22/2024 by MarketBeat.com Staff